Skip to content

O'Toole named VP of pharmacy services at Ahold Delhaize USA

Table of Contents

SALISBURY, N.C. — Moira O’Toole has been appointed vice president of pharmacy services at Ahold Delhaize USA.

Moira O'Toole

O'Toole and her team will provide pharmacy services to the company's local banners including prescription drug procurement, managed care reimbursement and network contracting, drug pricing, clinical program development, regulatory compliance, pharmacy systems administration and customer-facing service development.

“Moira is a proven leader who is committed to empowering associates to achieve their full potential.” said chief commercial and supply chain officer Roger Wheeler. “Her strong partnerships within our organization and industry are vital as we navigate the ever-evolving retail pharmacy space.”

With more than 24 years of experience with the companies of Ahold Delhaize USA, O'Toole most recently served as Director of Patient Health Services, where she oversaw payer contracting and clinical program management.

She started her career with Hannaford and brings to this role a deep understanding of retail pharmacy. She has held roles of increasing responsibility, including pharmacy intern, pharmacist and pharmacy operations manager and pharmacy business and project manager, interim pharmacy clinical program manager and director of pharmacy services and managed care.

She earned her Doctor of Pharmacy degree from Albany Collage of Pharmacy and a Master of Business Administration with a concentration in health systems from Clarkson University.

Outside of work, she enjoys hiking in the White Mountains, and runs a group that focuses on creating a safe, community environment to introduce new female hikers to the mountains.

She is based in Ahold Delhaize USA’s Scarborough, Maine, office.

Comments

Latest

Target stock plummets after Q3 earnings miss

Target stock plummets after Q3 earnings miss

Target reported mixed third-quarter results, with profits falling short due to cautious consumer spending and elevated operational costs. The retailer’s stock plunged over 20% as it lowered its full-year forecast and faced continued challenges in discretionary categories.